An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy
Top Cited Papers
- 28 March 2017
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 198 (2), 329-334
- https://doi.org/10.1016/j.juro.2017.01.103
Abstract
In this white paper update we identify and discuss the prevalence and prevention of common complications of prostate needle biopsy. A literature review was performed on prostate biopsy complications via queries of PubMed and EMBASE® databases for prostate biopsy complications from January 1, 2010 until June 1, 2015. We focused on infection, bleeding, urinary retention, needle tract seeding and erectile dysfunction. A total of 346 articles were identified for full text review and 119 are included in the final data synthesis. Infection is the most common complication of prostate biopsy with fluoroquinolone resistant Escherichia coli having a prominent role. Reported rates of infectious complications range from 0.1% to 7.0%, and sepsis rates range from 0.3% to 3.1% depending on antibiotic prophylaxis regimens. Mild, self-limiting and transient bleeding is also a common complication. Other complications are extremely rare. This white paper provides a concise reference document for the more common prostate biopsy complications and prevention strategies. Risk assessment should be performed for all patients to identify known risk factors for harboring fluoroquinolone resistance. If infection incidence increases check the local antibiogram, current equipment and cleaning practices, and consider alternate approaches to antibiotic prevention such as needle cleaning, risk basked augmentation, rectal culture with targeted prophylaxis and transperineal biopsy. If infection occurs, actively re-situate the patient and start empiric intravenous treatment with carbapenems, amikacin or second and third generation cephalosporins.Keywords
This publication has 20 references indexed in Scilit:
- Clinical and Microbiological Determinants of Infection After Transrectal Prostate BiopsyClinical Infectious Diseases, 2014
- Fluoroquinolone Resistant Rectal Colonization Predicts Risk of Infectious Complications after Transrectal Prostate BiopsyJournal of Urology, 2014
- Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysisInternational Journal of Antimicrobial Agents, 2014
- Outbreak of Fluoroquinolone-ResistantEscherichia coliInfections after Transrectal Ultrasound—Guided Biopsy of the ProstateInfection Control & Hospital Epidemiology, 2013
- Targeted Antimicrobial Prophylaxis Using Rectal Swab Cultures in Men Undergoing Transrectal Ultrasound Guided Prostate Biopsy is Associated With Reduced Incidence of Postoperative Infectious Complications and Cost of CareJournal of Urology, 2012
- Complications After Prostate Biopsy: Data From SEER-MedicareJournal of Urology, 2011
- Rising Incidence of Acute Prostatitis Following Prostate Biopsy: Fluoroquinolone Resistance and Exposure Is a Significant Risk FactorUrology, 2011
- Increasing Hospital Admission Rates for Urological Complications After Transrectal Ultrasound Guided Prostate BiopsyJournal of Urology, 2010
- Complications and risk factors of transrectal ultrasound guided needle biopsies of the prostate evaluated by questionnaireUrologic Oncology, 2008
- The Incidence of Fluoroquinolone Resistant Infections After Prostate Biopsy—Are Fluoroquinolones Still Effective Prophylaxis?Journal of Urology, 2008